1. Home
  2. KTOS vs INM Comparison

KTOS vs INM Comparison

Compare KTOS & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kratos Defense & Security Solutions Inc.

KTOS

Kratos Defense & Security Solutions Inc.

HOLD

Current Price

$75.41

Market Cap

11.7B

Sector

Industrials

ML Signal

HOLD

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$1.08

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTOS
INM
Founded
1994
1981
Country
United States
Canada
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
3.7M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
KTOS
INM
Price
$75.41
$1.08
Analyst Decision
Strong Buy
Analyst Count
14
0
Target Price
$84.00
N/A
AVG Volume (30 Days)
2.0M
155.5K
Earning Date
11-04-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
27.23
N/A
EPS
0.13
N/A
Revenue
$1,284,800,000.00
$4,798,116.00
Revenue This Year
$19.25
N/A
Revenue Next Year
$20.07
N/A
P/E Ratio
$601.10
N/A
Revenue Growth
14.00
N/A
52 Week Low
$23.90
$1.09
52 Week High
$112.57
$8.27

Technical Indicators

Market Signals
Indicator
KTOS
INM
Relative Strength Index (RSI) 47.29 33.56
Support Level $76.10 $1.18
Resistance Level $83.41 $1.35
Average True Range (ATR) 3.42 0.10
MACD 0.19 -0.00
Stochastic Oscillator 41.21 4.44

Price Performance

Historical Comparison
KTOS
INM

About KTOS Kratos Defense & Security Solutions Inc.

Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Share on Social Networks: